Literature DB >> 4538344

Plasma therapy in immunodeficiency diseases.

R H Buckley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4538344     DOI： 10.1001/archpedi.1972.02110150074014

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN： 0002-922X


× No keyword cloud information.
  5 in total

1.  Total C4B deficiency due to gene deletion and gene conversion in a patient with severe infections.

Authors:  Taina Jaatinen; Meri Lahti; Olli Ruuskanen; Riikka Kinos; Lennart Truedsson; Riitta Lahesmaa; Marja-Liisa Lokki
Journal:  Clin Diagn Lab Immunol       Date:  2003-03

2.  Factor affecting the in vitro assessment of opsonization: a study of the kinetics of opsonization using the technique of phagocytic chemiluminescence.

Authors:  A J Williams; M J Hastings; C S Easmon; P J Cole
Journal:  Immunology       Date:  1980-12       Impact factor: 7.397

3.  Intravenous gammaglobulin for immunodeficiency: report from The European Group for Immunodeficiencies (EGID).

Authors: 
Journal:  Clin Exp Immunol       Date:  1986-09       Impact factor: 4.330

Review 4.  Limited Innovations After More Than 65 Years of Immunoglobulin Replacement Therapy: Potential of IgA- and IgM-Enriched Formulations to Prevent Bacterial Respiratory Tract Infections.

Authors:  Jeroen D Langereis; Michiel van der Flier; Marien I de Jonge
Journal:  Front Immunol       Date:  2018-08-23       Impact factor: 7.561

5.  Plasma therapy leads to an increase in functional IgA and IgM concentration in the blood and saliva of a patient with X-linked agammaglobulinemia.

Authors:  Jeroen D Langereis; Joannes F M Jacobs; Marien I de Jonge; Marcel van Deuren
Journal:  J Transl Med       Date:  2019-05-23       Impact factor: 5.531
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.